Isnain, Sitti Farrah S.

HRN: 28-53-97  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/13/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/13/2026
07/20/2026
IV
70mg
Q8h
Amoebiasis
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: No  Wrong Dose 

Intervention



Type of Intervention done:

                    

           


Acceptance: